ENGERIX-B
Hepatitis B surface antigen (recombinant) · Hepatitis B
Health Canada DIN 02487039. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- ENGERIX-B
- DIN
02487039- Vaccine
- Hepatitis B surface antigen (recombinant)
- Presentation
- 20 mcg / 1 mL · suspension · intramuscular · 20 years and older; 11 to 15 two-dose; dialysis as a double dose
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| Hepatitis B — standard three-dose series Standard hepatitis B series at months 0, 1 and 6. | 3 doses | Minimum intervals: 4 weeks between doses 1 and 2, 2 months between doses 2 and 3, and 4 months between doses 1 and 3. The age-appropriate product and dose are chosen by the Care365 clinical team; blood testing after the series is needed for some people. |
| Hepatitis B — adolescents 11 to 15 years, two doses (adult dose) Two adult-strength doses at months 0 and 4 to 6, for adolescents 11 to less than 16 years. | 2 doses | For 11 to less than 16 years of age, the standard adult dose (RECOMBIVAX HB 10 mcg, or ENGERIX-B 20 mcg) may be given as two doses, the second 4 to 6 months after the first, when a three-dose series is unlikely to be completed. |
| Hepatitis B (ENGERIX-B, double dose) — dialysis or weakened immune system, four doses Two 20 mcg injections at each of months 0, 1, 2 and 6. | 4 doses | For adults 20 years and older on dialysis, with chronic renal failure or with some immunocompromising conditions, using ENGERIX-B at double the usual dose (40 mcg) at months 0, 1, 2 and 6. Blood testing after the series is required. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Recommended for people without immunity who are at high risk of exposure.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Hepatitis B vaccines: Canadian Immunization Guide — Chapter revised March 2017 · erratum May 2022
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365